Virtus Advisers LLC Buys New Shares in Aveanna Healthcare Holdings Inc. $AVAH

Virtus Advisers LLC bought a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 42,390 shares of the company’s stock, valued at approximately $363,000.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after buying an additional 1,535,351 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Aveanna Healthcare by 49.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock valued at $8,593,000 after acquiring an additional 441,707 shares in the last quarter. Segall Bryant & Hamill LLC lifted its stake in Aveanna Healthcare by 425.8% in the first quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock worth $1,056,000 after acquiring an additional 132,779 shares during the last quarter. Weiss Asset Management LP acquired a new position in Aveanna Healthcare during the 1st quarter worth approximately $732,000. Finally, Principal Financial Group Inc. acquired a new position in Aveanna Healthcare during the 1st quarter worth approximately $895,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder Paul R. Vigano sold 3,000,000 shares of the stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $24,030,000.00. Following the completion of the sale, the insider directly owned 190,130 shares of the company’s stock, valued at approximately $1,522,941.30. This represents a 94.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 3,000,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total transaction of $24,030,000.00. Following the transaction, the insider owned 190,130 shares in the company, valued at approximately $1,522,941.30. This trade represents a 94.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 31,180,664 shares of company stock worth $214,607,160. Corporate insiders own 5.30% of the company’s stock.

Aveanna Healthcare Trading Up 1.5%

NASDAQ AVAH opened at $13.16 on Friday. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. The firm’s fifty day moving average price is $9.58 and its 200 day moving average price is $7.92. The company has a market capitalization of $2.87 billion, a price-to-earnings ratio of 10.70, a price-to-earnings-growth ratio of 0.91 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a 12 month low of $5.93 and a 12 month high of $13.61.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. On average, sell-side analysts expect that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on AVAH shares. Truist Financial raised their price objective on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. UBS Group boosted their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. Wall Street Zen cut Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $10.00 to $11.00 in a report on Friday, May 15th. Finally, Raymond James Financial upped their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Aveanna Healthcare has a consensus rating of “Moderate Buy” and an average target price of $11.78.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.